Ramzi M Mohammad

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 8

Top Topics

Neuroendocrine Tumors

Tyrosine Kinase

Long Noncoding Rna

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Yiwei Li, Mohammed Najeeb Al Hallak, Philip A Philip, Asfar S Azmi, Ramzi M Mohammad
Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs. Cancers 13 (16) (2021)
Husain Yar Khan, Mohammed H Uddin, Suresh Kumar Balasubramanian, Noor Sulaiman, Marium Iqbal, Mahmoud Chaker, Amro Aboukameel, Yiwei Li, William Senapedis, Erkan Baloglu, Ramzi M Mohammad, Jeffrey Zonder, Asfar S Azmi
PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma. Cancers 14 (1) (2021)
Mohammed H Uddin, Mohammed Najeeb Al-Hallak, Philip A Philip, Ramzi M Mohammad, Nerissa Viola, Kay-Uwe Wagner, Asfar S Azmi
Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside. Cancers 13 (11) (2021)
Husain Yar Khan, Gabriel B Mpilla, Rachel Sexton, Srikant Viswanadha, Kumar V Penmetsa, Amro Aboukameel, Maria Diab, Mandana Kamgar, Mohammad Najeeb Al-Hallak, Mark Szlaczky, Anteneh Tesfaye, Steve Kim, Philip A Philip, Ramzi M Mohammad, Asfar S Azmi
Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth. Cancers 12 (3) (2020)
Gabriel B Mpilla, Amro Aboukameel, Irfana Muqbil, Steve H Kim, Rafic Beydoun, Philip A Philip, Ramzi M Mohammad, Mandana Kamgar, Vinod Shidham, William Senapedis, Erkan Baloglu, Jing Li, Gregory Dyson, Yue Xue, Bassel El-Rayes, Asfar S Azmi
PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors. Cancers 11 (12) (2019)
Asfar S Azmi, Yiwei Li, Amro Aboukameel, Irfana Muqbil, Philip A Philip, Ramzi M Mohammad
DNA-Methylation-Caused Downregulation of miR-30 Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal Adenocarcinoma. Cancers 11 (8) (2019)
Husain Yar Khan, James Ge, Misako Nagasaka, Amro Aboukameel, Gabriel B Mpilla, Irfana Muqbil, Mark Szlaczky, Mahmoud Chaker, Erkan Baloglu, Yosef Landesman, Ramzi M Mohammad, Asfar S Azmi, Ammar Sukari
Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance. International journal of molecular sciences 21 (1) (2019)
Irfana Muqbil, Asfar S Azmi, Ramzi M Mohammad
Nuclear Export Inhibition for Pancreatic Cancer Therapy. Cancers 10 (5) (2018)